GGrantIndex
Sort

78,016 grants matching breast cancer

NCTN Deep South Research Consortium

$482,362
Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2022 · CA

Computational Approaches for RNA StructureFunction Determination

$482,357
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Massive Genome Informatics

$482,331
Robert Bushel · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Volumetric mapping of Breast Cancer Biomarkers using high-speed MR Spectroscopic

$482,311
Stefan Posse · University Of New Mexico · RC1 · FY2010 · EB

Advanced PET System Dedicated to Breast Cancer Imaging

$482,304
Craig S Levin · Stanford University · R01 · FY2007 · CA

Targeting the Epidermal Growth Factor Receptor (EGFR) to Revert Trastuzumab Deruxtecan Resistance in HER2-low Colorectal Cancer.

$482,236
Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Cell and Cancer Biology Branch Confocal Microscopy Core

$482,217
Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Biologic Specimen Management Core

$482,207
Shelley S Tworoger · Brigham And Women'S Hospital · P01 · FY2013 · CA

Next generation deep tissue quantitative optical imaging

$482,197
Thomas D Osullivan · University Of Notre Dame · R01 · FY2022 · EB

Molecular Analysis of Human Breast Cancer

$482,179
Robert R. Clarke · Georgetown University · R01 · FY2006 · CA

Cyclin Dependent Kinases as Epigenetic Therapy Targets

$482,163
Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2021 · CA

Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland

$482,133
Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2025 · CA

De-implementation of Mammography Overuse in Older Racially and Ethnically Diverse Women

$482,122
Parisa Tehranifar · Columbia University Health Sciences · R01 · FY2024 · CA

Membrane-based immunotherapy for triple negative breast cancer- a partnered approach

$482,114
Periasamy Selvaraj · Emory University · R01 · FY2017 · CA

Chemotherapy & Cognition in Older breast Cancer Patients

$482,105
James P Grigsby · University Of Colorado Denver · R01 · FY2008 · AG

The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis

$482,102
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2023 · CA

Antibody-dual drug conjugates for eradicating triple-negative breast cancer with heterogeneity

$482,056
Kyoji Tsuchikama · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA

A partnership to enable clinical ctDNA testing for breast cancer recurrence

$481,993
Katherine Elena Varley · University Of Utah · R01 · FY2016 · CA

Novel taxane-site tubulin ligands with a dual apoptosis and senescence-inducing mechanism of action

$481,953
Hayley M. McDaid · Albert Einstein College Of Medicine · R01 · FY2025 · CA

The biochemical, topological and functional impact of cancer associated Ctcf mutations and their contribution to cancer

$481,945
Jane Amanda Skok · New York University School Of Medicine · R01 · FY2018 · CA

Maintaining Physical Activity in Ethnic Minority Women

$481,937
Rebecca E Lee · University Of Houston · R01 · FY2006 · CA

Understanding the impact of chemotherapy on breast cancer metastasis and immune function in the liver

$481,921
Sandra S McAllister · Brigham And Women'S Hospital · R01 · FY2025 · CA

Development of VN/14-1 and Related Analogs for Breast Cancer Therapy

$481,921
Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2014 · CA

Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity

$481,850
Shizhen Emily Wang · University Of California, San Diego · R01 · FY2021 · CA

Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity

$481,850
Shizhen Emily Wang · University Of California, San Diego · R01 · FY2020 · CA